Sec. 2. Reauthorization of the C.W. Bill Young Cell Transplantation Program
349 words·~2 min read·
/bill/116/hr/4764/eas/section-2A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Subsection
(a)of section 379 of the Public Health Service Act ( 42 U.S.C. 274k ) is amended by adding at the end the following new paragraph: The Secretary shall convene the Advisory Council at least two times each calendar year. . Effective as if included in the enactment of Public Law 114–104 (the Stem Cell Therapeutic and Research Reauthorization Act of 2015), the amendment to section 379(d)(2)(B) of the Public Health Service Act ( 42 U.S.C. 274k(d)(2)(B) ) in section 2(a)(2) of Public Law 114–104 is amended by inserting goal of increasing collections of high quality before cord blood units, . Subparagraph
(B)of section 379(d)(2) of the Public Health Service Act ( 42 U.S.C. 274k(d)(2) ) is amended by striking the second and third sentences in such subparagraph. Section 379 of the Public Health Service Act ( 42 U.S.C. 274k ) is amended by adding at the end the following new subsection: Not less than every two years, the Secretary, in consultation with the Director of the National Institutes of Health, the Commissioner of Food and Drugs, the Administrator of the Health Resources and Services Administration, the Advisory Council, and other stakeholders, where appropriate given relevant expertise, shall conduct a review of the state of the science of using adult stem cells and birthing tissues to develop new types of therapies for patients, for the purpose of considering the potential inclusion of such new types of therapies in the Program. Not later than June 30, 2024, the Secretary shall— complete the second review required by paragraph (1); and informed by such review, submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives recommendations on the appropriateness of the inclusion of new types of therapies in the Program. . Section 379B of the Public Health Service Act ( 42 U.S.C. 274m ) is amended by striking $33,000,000 for fiscal year 2015 and $30,000,000 for each of fiscal years 2016 through 2020 and inserting $30,000,000 for each of fiscal years 2021 through 2025 .
Connectionstraces to 3
Traces to 3 documents
Citation graph
cites case law
Sec. 2
Reauthorization of the C.W. Bill Young Cell Transplantation Program
Cites 3Cited by 0 across 0 sources